TheProfitWatch

RGNX - REGENXBIO Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
11.0 0.89 (8.09%) 0.0 (0.0%) 0.0 (0.0%) 0.01 (0.08%) -0.08 (-0.73%) 1.02 (9.38%) 0.0 (0.0%) 0.21 (1.96%)

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.38
Diluted EPS:
-1.38
Basic P/E:
-8.6159
Diluted P/E:
-8.6159
RSI(14) 1m:
57.14
VWAP:
11.88
RVol:

Events

Period Kind Movement Occurred At

Related News